In the second year of Covid-19, healthcare private equity activity showed remarkable resilience to the widespread disruption. In our 11th annual report, you’ll find detailed analysis of the major trends sweeping through healthcare investing.
DealEdge® is the private equity industry’s leading provider of deal-level performance and operational analytics. Get groundbreaking deal-level analysis of PE healthcare performance, value creation, and more in our latest report. DealEdge’s inaugural Sector Study covers 1,500 deals across 62 healthcare subsectors, ranging from Retail Health to MedTech.
